MaRS Centre, West Tower
661 University Avenue, Suite 465
About Fibrocor Therapeutics
Fibrocor will focus on developing therapeutics for fibrotic diseases.
Founders: Richard Gilbert, Jeff Wrana, and Darren Yuen
CEO: Mark Steedman
3 articles with Fibrocor Therapeutics
Based in Toronto, Ontario, Fibrocor Therapeutics was launched in January 2017.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.